معرفی
Dr. Quyen D. Chu serves as the Roy L. Schneider Endowed Professor of Surgery and Chief of Surgical Oncology at Howard University College of Medicine, concurrently holding the position of Associate Director of the Cancer Center. With over two decades of surgical expertise, he specializes in complex oncological procedures including gastrointestinal malignancies, sarcomas, skin cancers, and cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
His academic foundation includes a Bachelor of Arts from Dartmouth College (1986-1990), Doctor of Medicine from Brown University School of Medicine (1990-1994), and Executive MBA from Centenary College (2011-2013). Clinical training encompassed general surgery residency at St. Elizabeth's Medical Center (serving as chief resident) and surgical oncology fellowship at Roswell Park Cancer Institute.
Dr. Chu's research spans hepatopancreatobiliary surgery, gastrointestinal cancer therapeutics, and innovative applications of gene therapy in peritoneal carcinomatosis models. His humanitarian work drives international surgical missions across Vietnam, Kurdistan, and Nicaragua, while his patient navigation programs significantly advance breast cancer care in underserved communities.
His distinguished honors include multiple humanitarian awards from ASCO and AHPBA, Ellis-Island Medals of Honor, and prestigious traveling fellowships recognizing global surgical leadership. These accolades underscore his dual commitment to clinical excellence and international health equity.
As a prolific grant recipient, Dr. Chu secured over $1.7 million in research funding as Principal Investigator from Feist-Weiller Cancer Grant, Susan G. Komen Foundation, Vietnam Education Foundation, and Department of Defense. His funded projects address critical gaps in pancreatic cancer gene therapy, breast cancer navigation systems, and integrin signaling mechanisms, while pharmaceutical-sponsored symposia advanced hepatobiliary carcinoma education across Louisiana.
